🇺🇸 FDA
Patent

US 11166976

S-antigen transport inhibiting oligonucleotide polymers and methods

granted A61KA61K31/7125A61K9/0019

Quick answer

US patent 11166976 (S-antigen transport inhibiting oligonucleotide polymers and methods) held by Aligos Therapeutics, Inc. expires Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Aligos Therapeutics, Inc.
Grant date
Tue Nov 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/7125, A61K9/0019, A61P, A61P31/20